Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2009;104:1136-1138
doi: 10.1161/CIRCRESAHA.109.198911
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gladwin, M. T.
Right arrow Articles by Shiva, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gladwin, M. T.
Right arrow Articles by Shiva, S.
Related Collections
Right arrowRelated Article
(Circulation Research. 2009;104:1136.)
© 2009 American Heart Association, Inc.


Editorials

The Ligand Binding Battle at Cytochrome c Oxidase

How NO Regulates Oxygen Gradients in Tissue

Mark T. Gladwin, Sruti Shiva

From Pulmonary, Allergy and Critical Care Medicine (M.T.G.); the Department of Pharmacology and Chemical Biology (S.S.); and the Hemostasis and Vascular Biology Research Institute (M.T.G., S.S.), University of Pittsburgh, Pa.

Correspondence to Dr Mark T. Gladwin, Pulmonary, Allergy and Critical Care Medicine, Hemostasis and Vascular Biology Research Institute, University of Pittsburgh, NW 628 Montefiore Hospital, 3459 Fifth Ave, Pittsburgh, PA 15213. E-mail gladwinmt@upmc.edu



See related article, pages 1178–1183


Key Words: microcirculation • nitric oxide • nitric oxide synthase • reperfusion injury • hemoglobin


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
The discovery that a high-affinity heme ligand, nitric oxide (NO), was a critical regulator of vasodilation, hemostasis, and vascular inflammation, immediately presented a number of stark paradoxes. Most notably, the formation of NO in endothelium and tissue could increase oxygen delivery to tissue by direct vasodilation and recruitment of oxygen rich blood but paradoxically could compete directly with critical oxygen binding sites on oxygen carrier and storage proteins (ie, hemoglobin and myoglobin) and on heme proteins of the mitochondrial electron transport chain (METC). Consistent with such an activity for NO, it was recognized that NO binds with relatively high affinity to cytochrome c oxidase (complex IV) of the METC.1–3 Thus, the paradox: why would a molecule that is apparently essential for vasodilation and oxygen delivery directly bind to and inhibit mitochondrial electron transport? Such an activity, by inhibition of respiration and subsequent ATP generation, could represent an innate poison pill, analogous to cyanide.

Interestingly, the binding of NO to cytochrome c oxidase is unique for 2 major reasons (1) Unlike the binding of NO to deoxyhemoglobin or myoglobin, which has a very low dissociation rate, the binding of NO to cytochrome c oxidase is reversible; NO is released as the enzyme cycles. This means that NO-dependent inhibition of respiration is reversible.1,3 (2) Perhaps more importantly, the binding of NO to cytochrome c oxidase is regulated by oxygen, such that NO is a more potent inhibitor of respiration as oxygen tension decreases.1,3,4

The binding of NO to cytochrome c oxidase and . . . [Full Text of this Article]


Related Article:

Regulation of Oxygen Distribution in Tissues by Endothelial Nitric Oxide
Victor M. Victor, Cristina Nuñez, Pilar D'Ocón, Cormac T. Taylor, Juan V. Esplugues, and Salvador Moncada
Circ. Res. 2009 104: 1178-1183. [Abstract] [Full Text] [PDF]